Jered V. McGivern

ORCID: 0000-0001-5534-8571
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pluripotent Stem Cells Research
  • RNA modifications and cancer
  • Neurogenetic and Muscular Disorders Research
  • 3D Printing in Biomedical Research
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • CRISPR and Genetic Engineering
  • RNA regulation and disease
  • Cytomegalovirus and herpesvirus research
  • Advanced Chemical Sensor Technologies
  • Infectious Encephalopathies and Encephalitis
  • Listeria monocytogenes in Food Safety
  • Biomedical Ethics and Regulation
  • Genomics and Chromatin Dynamics
  • Tissue Engineering and Regenerative Medicine
  • RNA Interference and Gene Delivery
  • Mycotoxins in Agriculture and Food
  • Muscle Physiology and Disorders
  • Competitive and Knowledge Intelligence
  • Advanced Proteomics Techniques and Applications
  • Neurogenesis and neuroplasticity mechanisms
  • Anesthesia and Neurotoxicity Research
  • Mass Spectrometry Techniques and Applications
  • Physiological and biochemical adaptations
  • Cardiac Ischemia and Reperfusion

Medical College of Wisconsin
2012-2023

Lakeland College
2023

University of Wisconsin–Madison
2008-2009

Spinal muscular atrophy (SMA) is a genetic disorder caused by the deletion of survival motor neuron 1 ( SMN1 ) gene that leads to loss neurons in spinal cord. Although are selectively lost during SMA pathology, selective replacement SMN does not lead full rescue mouse models. Due ubiquitous expression SMN, it likely other cell types besides affected its disruption and therefore may contribute disease pathology. Here we show astrocytes SMAΔ7 cord from SMA‐induced pluripotent stem cells...

10.1002/glia.22522 article EN Glia 2013-07-10

Spinal muscular atrophy (SMA) is a genetic disorder caused by deletion of the survival motor neuron 1 gene leading to loss, muscle atrophy, paralysis, and death. We show here that induced pluripotent stem cell (iPSC) lines generated from two Type I SMA subjects–one produced with lentiviral constructs second using virus-free plasmid–based approach–recapitulate disease phenotype generate significantly fewer neurons at later developmental time periods in culture compared separate control...

10.1371/journal.pone.0039113 article EN cc-by PLoS ONE 2012-06-19

Abstract Using stem cells to replace degenerating muscle and restore lost skeletal function is an attractive therapeutic strategy for treating neuromuscular diseases. Myogenic progenitors are a valuable cell type cell-based therapy also provide platform studying normal development disease mechanisms in vitro. Human pluripotent represent source of tissue generating myogenic progenitors. Here, we present novel protocol deriving from human embryonic (hES) induced (iPS) using free-floating...

10.5966/sctm.2013-0143 article EN cc-by-nc Stem Cells Translational Medicine 2014-03-21

Dystrophin-deficient cardiomyopathy is a growing clinical problem without targeted treatments. We investigated whether nicorandil promotes cardioprotection in human dystrophin-deficient induced pluripotent stem cell (iPSC)-derived cardiomyocytes and the muscular dystrophy mdx mouse heart.Dystrophin-deficient iPSC-derived had decreased levels of endothelial nitric oxide synthase neuronal synthase. The increased injury death after 2 hours stress recovery. This was associated with reactive...

10.1177/1074248416636477 article EN Journal of Cardiovascular Pharmacology and Therapeutics 2016-03-04

Abstract Phosphorylation is universally used for controlling protein function, but knowledge of the phosphoproteome in vertebrate embryos has been limited. However, recent technical advances make it possible to define an organism's at a more comprehensive level. Xenopus laevis offers established advantages analyzing regulation function by phosphorylation. Functionally unbiased, information about would provide powerful guide future studies phosphorylation developmental context. To this end,...

10.1002/dvdy.21941 article EN Developmental Dynamics 2009-04-21

We identified a functional domain (XlePABP2-TRP) of Xenopus laevis embryonic type II poly(A)-binding protein (XlePABP2). The NMR structure XlePABP2-TRP revealed that the is homodimer formed by antiparallel association beta-strands from single RNA recognition motif (RRM) each subunit. In subunit homodimer, canonical site occluded polyproline motif. Upon poly(A) binding, undergoes dimer-monomer transition removes and allows it to be replaced adenosine nucleotides poly(A). Our results provide...

10.1073/pnas.0801274105 article EN Proceedings of the National Academy of Sciences 2008-09-30

The xCR1 protein is a maternal determinant and cofactor for nodal signaling in vertebrate embryos. accumulates specifically the animal cells of Xenopus embryos, but mRNA distributed equally throughout all embryonic cells. Here, we show that vegetal cell-specific translational repression contributes to this spatially restricted accumulation was associated with polyribosomes not A 351-nucleotide region mRNA's 3′ untranslated sufficient confer pattern translation luciferase reporter by...

10.1128/mcb.01865-08 article EN Molecular and Cellular Biology 2009-04-14

Spinal muscular atrophy (SMA), the top genetic cause of infant mortality, is characterized by motor neuron degeneration. Mechanisms underlying SMA pathogenesis remain largely unknown. Here, we report that activity cyclin-dependent kinase 5 (Cdk5) and conversion its activating subunit p35 to more potent activator p25 are significantly up-regulated in mouse models human induced pluripotent stem cell (iPSC) SMA. The increase Cdk5 occurs before onset phenotypes, suggesting it may be an initiator...

10.1073/pnas.2300308120 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2023-11-17

University based technology transfer offices function to identify, protect, and market new technologies all of which require strategic decisions about developed at their institutions. Often, limited time resources are available for pursuing patent protection identifying commercial partners licensing. Therefore, determining have high probabilities success is necessary. The collection data regarding the market, referred as competitive intelligence, helps make these decisions. In this article...

10.2174/2213809901666131207010049 article EN Technology Transfer and Entrepreneurship 2013-12-06
Coming Soon ...